U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07318792) titled 'Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds' on Jan. 04.
Brief Summary: Platelet-based therapies have been used to treat bony and soft tissue effects for more than 30 years. Tropocells(R) Autologous Platelet-Rich Fibrin (PRF) is being used to treat chronic, non-healing wounds, of a variety of types. This will help determine the safety and effective use of PRF in the treatment of soft tissue defects.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Wound Chronic Draining
Wound Closure
Intervention:
DEVICE: Platelet-rich fibrin (PRF)
Standard of Care will include-...